We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Royalty Pharma PLC | NASDAQ:RPRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.295 | -1.09% | 26.89 | 26.68 | 40.50 | 27.20 | 26.705 | 27.15 | 1,907,850 | 05:00:07 |
Delaware
|
001-15281
|
76-0233274
|
(State
or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
2408
Timberloch Place, Suite B-7
The
Woodlands, Texas 77380
(Address
of principal
executive
offices
and
zip code)
|
||
(281)
719-3400
(Registrant’s
telephone number, including area code)
|
Exhibit
|
||
Number
|
Description | |
99.1
|
Press
Release dated January 27,
2010
|
Repros Therapeutics Inc. | |||
Date: January
27, 2010
|
By:
|
/s/ Joseph S. Podolski | |
Joseph S. Podolski | |||
President and Chief Executive Officer |
Exhibit
|
||
Number
|
Description | |
99.1
|
Press
Release dated January 27, 2010
|
1 Year Royalty Pharma Chart |
1 Month Royalty Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions